Navigation Links
ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options
Date:9/17/2008

Results of the National CT Colonography Trial Raise Questions for Patients

OAK BROOK, Ill., Sept. 17 /PRNewswire-USNewswire/ -- Results of the National CT Colonography Trial, published in the September 18 issue of the New England Journal of Medicine, show improvements in the technology's ability to diagnose intermediate- to large-sized polyps in the colon, but this method of testing is not as effective in diagnosing small polyps. CT colonography is one of several colorectal cancer screening options. The American Society for Gastrointestinal Endoscopy (ASGE) encourages patients to speak to their doctor about the screening method that is best for them.

"Colorectal cancer is largely preventable and curable when diagnosed in its early stages. Screening saves lives. Unfortunately, far too few people undergo screening for colorectal cancer. Any advances that result in increased screening of the population are encouraging," said ASGE President John L. Petrini, M.D., FASGE. "The results of this trial may prompt those who otherwise would have avoided being tested, to get screened for colorectal cancer. With so many different options to screen for colorectal cancer, it is important to talk to your doctor and discuss which screening method is best for you. Each screening option has appropriate applications and limitations."

CT colonography, also referred to as virtual colonoscopy, relies on a computer program to generate a 3D picture of the large intestine (colon) using x-ray images. This differs from colonoscopy, which provides actual photos of the colon and rectum via a camera attached to a thin, flexible scope that is physically guided through the large intestine.

The results of the National CT Colonography Trial have shown some improvements in the ability of CT colonography to diagnose intermediate- to large-sized polyps. Complete data for 2,531 participants at 15 U.S. centers showed that CT colonography identified large colorectal adenom
'/>"/>

SOURCE American Society for Gastrointestinal Endoscopy
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
2. Childhood Influenza Immunization Coalition Encourages Vaccination Throughout the Influenza Season
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Holdings, Inc. today announced that it has been na...Technology Council (NJTC), a 1,200-member non-prof...tworking opportunities, information and advocacy f...earned the award based on criteria including marke... , , "We are delighted that the New Jersey ...
(Date:11/20/2008)... The following is being released by Center for Hea...AIDS Day Audio Media Conference , , WHEN:... EST , Call-in number: 1-800-949-8476 , RSVP...1xe41i2yre8rs , , WHY: With new HIV infe... treatment worldwide, advocates are calling on the...
(Date:11/20/2008)...GlaxoSmithKline (NYSE: ...and Drug Administration (FDA) granted accelerated ...atment of thrombocytopenia in patients with chroni...P) who have had an insufficient response to cortic...roval is a significant milestone for PROMACTA and ...
(Date:11/20/2008)...ire-FirstCall/ -- Arpida (SWX:,ARPN) announced to...ee of the,U.S. Food and Drug Administration (FDA)...enous iclaprim, an antibiotic currently in develop...ed skin and skin structure infections,(cSSSIs), i...phylococcus,aureus (MRSA). , Arpida remain...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Direct Relief International Aims California Fire Response at Health Concerns 4445 1Direct Relief International Aims California Fire Response at Health Concerns 4445 2Illinois Planning Board Approves Central DuPage Hospital Bed Pavilion 4442 1Illinois Planning Board Approves Central DuPage Hospital Bed Pavilion 4442 2IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 933 1IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 933 2IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 933 3Scripps Health Treats More Than 160 Fire Victims at Emergency Departments Across San Diego County 4440 1Scripps Health Treats More Than 160 Fire Victims at Emergency Departments Across San Diego County 4440 2
....Y.--(BUSINESS WIRE)--Jun 4, 2007 - Acorda,Therape... the,Company presented a "meta-analysis" or combin...R in multiple sclerosis during a,poster session at...,in MS (ACTRIMS) Meeting in Washington, D.C. on Sa...onsistent Improvement in Walking,Speed on the Time...
...SINESS WIRE)--Jun 4, 2007 - Cytogen Corporation,(N...trials,demonstrating that QUADRAMET (samarium Sm-1...d to prostate cancer patients who are also,receivi...-Aventis).,Clinical data also support further eval...t of prostate cancer in a Phase 2 program.,The res...
Other Medicine Technology:Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 2New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 3New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 4New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 5New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 6New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 7
(Date:11/22/2008)...0 don,t do enough to protect themselves from strok...ealthDay News) -- It,s one of medicine,s mantras: ...ower it will have a dramatic impact on your risk o...ent of people with high blood pressure still aren,...g to a U.S. Centers for Disease Control and Preven...
(Date:11/21/2008)...NTY, Calif., Nov. 21 Album Creativ...rm, launches a new program offering big brand mark...ken the large, expensive ad agency process and ser...a very hands-on approach," says Matt Parker, Creat...combines experience and proven brand-building tech...
(Date:11/21/2008)...ASSEE, Fla. -- A Florida State University College ... discovered an important new layer of regulation i...reater understanding of the way cancer begins. , ...es at the College of Medicine, said the findings w... and could lead to the design of new drugs that ki...
(Date:11/21/2008)...iz., Nov. 21 The Provide...nnounced that Craig A. Norris, the Company,s,Chie...pany,s Board of,Directors. Mr. Norris, appointme...nation of Steven I. Geringer and returns the board...y committee of the Board. , Mr. Norris, age...
Breaking Medicine News(10 mins):Health News:High Blood Pressure Stalks Many Americans 2Health News:High Blood Pressure Stalks Many Americans 3Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3
...rkable for its ability to live in the strong acid ...ccoli is powerful against the bacterium that is li.../ It's now well established that this microbe is r...Clearing it with antibiotics is an important form ...
...ggest that, some women who develop gestational dia...en with certain chromosomal abnormalities However,...tself a risk factor for these types of defects sin...l before gestational diabetes typically develops./...
... study on seedless green grapes which caused a sal...x Western states last summer and fall. Researchers...nella serotype senftenberg// most often found in m...to people through grapes. Dr.Alicia, at the Intern...
...utting their lives at risk because they fail to ex...embarrassed to consult their general practitioner ... their argument on a case study involving a young...t and suffered minor injuries. Four days later he ...
Other Medicine News:Health News:Gestational Diabetes linked to Chromosomal defici 2Health News:Grapes, Melons Implicated in Outbreaks 2Health News:Patients with testicular cancer dying through unfamiliarity 2